Skip to content
S6062Senate2011-2012 SessionSame asA7634

Prohibits the substitution of opioid analgesic drugs for an opioid analgesic drug incorporating tamper resistance technology

Sponsor Jack M. MartinsSD-7+6 co-sponsorsAffects Health
Status
In Senate Committee
Health
Impact
Pending
Passage
Pending

Bill progress

Step 2 of 7

In committee · Health

What's happening

Writing a plain-English summary… Track this bill to get it by email.

Why it matters

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Sponsors

History

  1. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A7634Assembly

Prohibits the substitution of opioid analgesic drugs for an opioid analgesic drug incorporating tamper resistance technology

In Assembly Committee · Higher Education · Sponsor Harry B. Bronson

Full text

The text isn't available here yet. Check nysenate.gov.

Sponsor's memo

BILL NUMBER:S6062

Title of bill

An act to amend the public health law, in relation to prohibiting the substitution of opioid analgesic drugs for an opioid analgesic drug incorporating tamper resistance technology

Purpose or general idea of bill

To ensure that every opioid analgesic drug is used for its proper purpose.

Summary of specific provisions

Section 1 adds a new section 3346 to the public health law to prohibit without physician over-ride the use of non-tamper resistance opioid analgesic drugs and make definitions of such. Section 2 is the effective date of the bill.

Justification

Opioid use and abuse has increased greatly in the United States since the 1590's and continues to rise while the benefits of these Products in treating and managing pain are widely recognized, the potential for misuse and abuse of these products has long been a concern of manufacturers, state and federal law enforcement, healthcare providers, legislators, and regulators. Under this proposal, when a physician prescribes an opioid analgesic drug that incorporates a tamper resistance technology, no substitution or interchange shall be permitted for that drug without the pharmacy, (1) verifying that the substitute provides substantially similar tamper resistance properties as determined by the State, or (2) obtaining the prior, written consent of the prescribing physician.

Prior legislative history

New Bill.

Fiscal implications

None.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.